Wells Fargo lowered Abbott Laboratories (NYSE:ABT) price target to $136

By / / Abbott, Wells Fargo

Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and lowers the price target from $140 to $136.

Scroll to Top